Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 1 33-1, 1996, Pages

  Luheshi, Giamal ^a   Miller, Andrew J ^b   Brouwer, Saskia ^b   Dascombe, Michael J ^b   Rothwell, Nancy J ^b   Hopkins, Stephen J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

cytokines; fever; lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; FEVER; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR AFFINITY;

EID: 0030064395     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.1.e91     Document Type: Article

References (31)

1. Atkins, E. Fever: historical perspectives and evolution of modern views. J. Rheumatol. Suppl. 24: 1-5, 1985.
2. Blatteis, C. M. Neuromodulative actions of cytokines. Yale J. Biol. Med. 63: 133-146, 1990.
3. Bluthe, R. M., R. Dantzer, and K. W. Kelly. Effects of interleukin-1 receptor antagonist on the behavioural effects of lipopolysaccharide in the rat. Brain Res. 573: 318-320, 1992.
4. Bristow, A. F., K. Mosley, and S. Poole. Interleukin-1β production in vivo and in vitro in rats and mice measured using specific immunoradiometric assay. J. Mol. Endocrinol. 7: 1-7, 1991.
5. Cannon, J. G., R. G. Tompkins, J. A. Gelfand, H. R. Michie, G. G. Stanford, J. W. M. van der Meer, S. Endres, G. Lonneman, J. Corsetti, B. Chernow, D. W. Wilmore, S. M. Wolff, J. F. Burke, and C. A. Dinarello. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161: 79-84, 1990.
6. Castell, J., J. Klapproth, V. Gross, E. Walter, T. Andus, L. Snyers, J. Content, and P. C. Heinrich. Fate of interleukin-6 in the rat: involvement of skin in its catabolism. Eur. J. Biochem. 189: 113-118, 1990.
7. Cooper, A. L., E. Kirkman, R. A. Little, S. J. Hopkins, and N. J. Rothwell. Mechanisms involved in the fever and hypermetabolism induced by turpentine injection in the rat (Abstract). Proc. Nutr. Soc. 50: 149A, 1991.
8. De Simoni, M. G., M. Sironi, A. De Luigi, A Manfridi, A. Montavani, and P. Ghezzie. Intracerebroventricular injection of interleukin-1 induces high circulating levels of interleukin-6. J. Exp. Med. 171: 1773-1778, 1990.
9. Dinarello, C. A. Interleukin-1 and interleukin-1 antagonists. Blood 77: 1627-1652, 1991.
10. Dripps, D. J., B. J. Brandhuber, R. C. Thompson, and S. P. Eisenberg. Interleukin-1 (IL-1) receptor antagonist binds to the 80 kDa IL-1 receptor, but does not initiate IL-1 signal transduction. J. Biol. Chem. 266: 10331-10336, 1991.
11. Eisenberg, S. P., R. J. Evans, W. P. Arend, E. Verderber, M. T. Brewer, C. H. Hannum, and R. C. Thompson. Primary-structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature Lond. 343: 341-346, 1990.
12. Engel, A., W. V. Kern, G. Murdter, and P. Kern. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumour necrosis factor a and interleukin-1β in patients with fever and neutropenia. Infection 22: 160-164, 1994.
13. Epstein, A. N., J. T. Fitzsimons, and B. J. Rolls. Drinking induced by injection of angiotensin into the brain of a rat. J. Physiol. Lond. 210: 457-474, 1970.
14. Hannum, C. H., C. J. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, J. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature Lond. 343: 336-340, 1990.
15. Helle, M., J. P. J. Brakenhoff, E. R. De Groot, and L. A. Aarden. Interleukin-6 is involved in interleukin-1-induced activities. Eur. J. Immunol. 18: 957-959, 1988.
16. Holt, I., R. G. Cooper, and S. J. Hopkins. Relationship between inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur. J. Clin. Invest. 21: 479-484, 1991.
17. Kluger, M. J. Fever: the role of pyrogens and cryogens. Physiol. Rev. 71: 92-127, 1991.
18. Krueger, J. M., F. Obal, M. Opp, L. Tota, L. Johennsen, and A. B. Cady. Somnogenic cytokines and models concerning their effect on sleep. Yale J. Biol. Med. 63: 157-162, 1990.
19. Krueger, J. M., J. Walter, C. A. Dinarello, S. M. Wolff, and L. Chedid. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 246 (Regulatory Integrative Comp. Physiol. 15): R994-R999, 1984.
20. Kushner, I. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389: 39-48, 1982.
21. LeMay, L. G., I. G. Otterness, A. J. Vander, and M. J. Kluger. In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1β. Cytokine 2: 199-204, 1990.
22. LeMay, L. G., A. J. Vander, and M. J. Kluger. Role of interleukin 6 in fever in rats. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R798-R803, 1990.
23. Long, N. C., I. Otterness, S. L. Kunkel, A. J. Vander, and M. J. Kluger. Roles of interleukin-1β and tumor necrosis factor in lipopolysaccharide fever in rats. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R724-R728, 1990.
24. Nijsten, M. W. N., E. R. deGroot, H. R. tenDuis, H. J. Klasen, C. E. Hack, and L. A. Aarden. Serum levels of interleukin-6 and acute phase responses. Lancet ii: 921, 1987.
25. Opp, M. R., and J. M. Kruger. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R453-R457, 1991.
26. Rothwell, N. J., N. J. Busbridge, H. Humphray, and P. Hissey. Central actions of interleukin-1β on fever and thermogenesis. Cytokine 1: 153, 1989.
27. Rothwell, N. J., N. J. Busbridge, R. A. LeFevure, A. J. Hardwick, J. Gauldie, and S. J. Hopkins. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can. J. Physiol. Pharmacol. 69: 1465-1469, 1991.
28. Sakata, Y., A. Morimoto, N. C. Long, and N. Murakami. Fever and acute-phase response induced in rabbits by intravenous and intracerebroventricular injection of interleukin-6. Cytokine 3: 199-203, 1991.
29. Smith, B. K., and M. J. Kluger. Human IL-1 receptor antagonist partially suppresses LPS fever but not plasma levels of IL-6 in Fischer rats. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R653-R655, 1992.
30. Uehara, A., C. Sekiya, Y. Takasugi, M. Namiki, and A. Arimura. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R613-R617, 1989.
31. Whicher, J. T., J. Gauldie, H. Baumann, and C. Westacott. Acute phase response proteins. In: Interleukin-1, Inflammation and Disease. Amsterdam: Elsevier, 1989, p. 191-216.